Menu

Blog

Page 2477

Mar 1, 2023

Agi: Artificial Neural Nets

Posted by in category: robotics/AI

ENGINEERING POINT OF VIEW

Mar 1, 2023

Study suggests changes in gambling behavior linked to suicide risk in young adults

Posted by in category: health

An increase in difficulties with gambling is linked to a heightened risk of suicide attempts among young adults, according to new research from the University of Glasgow and City, University of London.

Published in the journal, The Lancet Public Health, the study suggests that over the course of a year, (aged 16–24) who experienced an increase in severity of harm were 2.74 times more likely to attempt than those whose gambling was unchanged.

Gambling behavior is dynamic, and the study found that any escalation in the experience of gambling harm, regardless of someone’s starting point, was linked to a heightened risk of suicidality.

Mar 1, 2023

Observing Cells in Their Natural State with Digital Holographic Cytometry

Posted by in category: engineering

Technological and engineering advances let researchers delve deeper into cell function and behavior in physiological and pathological settings.

Mar 1, 2023

NASA Gave The Orville A Cool Shoutout, So Maybe Season 4 Will Happen Now?

Posted by in category: space

NASA showed some love to The Orville, and I’m thinking it’s time for an announcement that Season 4 is happening already.

Mar 1, 2023

Will AI take your job? ‘No one is safe from this’ — Alan Thompson

Posted by in categories: cryptocurrencies, economics, finance, military, robotics/AI, singularity, transhumanism

Alan Thompson, AI Consultant and Former Chairman of Mensa International, examines the latest trends in artificial intelligence, as well as its applications to finance, professional services, and military. He discusses the possibility that AI could become sentient and even dangerous with David Lin, Anchor and Producer at Kitco News.

Alan Thompson’s website: https://lifearchitect.ai/about-alan/

Continue reading “Will AI take your job? ‘No one is safe from this’ — Alan Thompson” »

Mar 1, 2023

Devil’s Honeycomb

Posted by in category: futurism

The St. Francois Mountains of the Ozarks are full of geological wonders. Most know of the smooth shut-ins of the Black River or the house-size red boulders of Elephant Rocks State Park. But the Hughes Mountain Natural Area brings a site overlooked by tourists—the Devil’s Honeycomb.

The trail to the honeycombs can be a bit daunting, but the rewards are well worth it. In addition to sweeping views of Washington county, 1.5 billion-year-old Precambrian rock outcrops multiple at the mountain peak. These are some of the oldest exposed rocks in the United States. Volcanoes once liquified rocks in the area helping form the multi-sided rock columns. The rhyolite formations, known locally as the Devil’s Honeycomb, are one of Missouri’s geologic wonders. They are deep red in color and covered in sea-green lichens.

In the spring and summer, wildflowers fill in the cracks of the honeycomb. Rain pools in between the rhyolite, creating little bird baths. Lizards soak up the sun upon the rocks. Even prickly pear cactus grows in the heat of the honeycomb.

Mar 1, 2023

How gut bacteria can impact treatments for cancer

Posted by in category: biotech/medical

A large team of cancer researchers affiliated with multiple institutions in Germany, working with a colleague from the U.S., has discovered some of the ways gut bacteria can positively impact treatments for cancer. In their study, published in the journal Nature, the group studied the impact of gut microbiota on chemotherapy given to patients with pancreatic ductal adenocarcinoma. Le Li and Florencia McAllister with the University of Texas MD Anderson Cancer Center, have published a News and Views piece in the same journal issue, outlining the work done by the team in Germany.

Prior research has shown that chemotherapy for that has metastasized sometimes works well but is sometimes ineffective, and this difference may be tied to dietary resistance, though its source is not known. In this new study, the team in Germany looked at the possibility that certain microorganisms in the play a role in the process.

The team began their work by looking at samples of the gut microbiome of pancreatic cancer patients and found differences between those responding to treatment and those who were not. They also found that mice with sterilized guts who received biome samples from mice responding to chemotherapy also responded well.

Mar 1, 2023

Got 11 minutes? A daily brisk walk could lower risk for early death

Posted by in categories: biotech/medical, health

A new study of 30 million people found that even small amounts of exercise could lower risk for heart disease, certain cancers and early death.

Mar 1, 2023

Endovascular Therapy Benefits Large Infarction: ANGEL-ASPECT

Posted by in category: biotech/medical

Patients with a large cerebral infarction have better functional recovery when they receive endovascular therapy early on in addition to usual medical management, a new study shows.

The trial was stopped early because a planned interim analysis showed efficacy of endovascular therapy in this patient population. #Stroke


A new study provides evidence for better functional recovery after endovascular therapy from a population of large-infarction strokes that could contribute to changing clinical practice.

Mar 1, 2023

Gene Therapy Clinical Trial for Frontotemporal Dementia Has Begun

Posted by in categories: biotech/medical, genetics, neuroscience

Bruce Willis has FTD. I always wondered if gene therapy could help. Apparently so did Passage Bio, and they are doing clinical trials.

FTD is a disorder that affects the frontal and temporal lobes of the brain, areas that control personality, executive function, and language. FTD is a form of early onset dementia and currently has no approved disease-modifying therapies. In approximately 5–10% of individuals with FTD, the disease occurs because of mutations in the GRN gene. These mutations cause a deficiency of progranulin that helps regulate cellular processes.

Continue reading “Gene Therapy Clinical Trial for Frontotemporal Dementia Has Begun” »